US Market Report for Optical Coherence Tomography 2017 – MedCore

US Market Report for Optical Coherence Tomography 2017 – MedCore

0

Optical coherence tomography (OCT) is a technique that allows physicians to acquire images of translucent or opaque material (such as biological tissue) at resolutions similar to low-power microscopes. The devices that make use of this technology to perform retinal imaging have become an integral part of tracking the progress of treatment and pathology for several important ocular diseases. The technique is often termed ‘optical ultrasound’ as imaging reflections within tissue are collected to provide cross-sectional images or topographic maps of the retinal surface. OCT is a non-invasive method of imaging the structure of the retina and provides physicians with information to detect ocular conditions such as macular holes, pre-retinal membranes, macular swelling or optic nerve damage. OCT devices are a particularly important diagnostic tool in the context of age-related macular degeneration (AMD).

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 4/1/2017
  • Pages: 207
  • Type: MedCore

General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
These hybrid devices—which combine OCT’s with devices such as fundus cameras, scanning laser ophthalmoscopes (SLO), or angiography devices—allow ophthalmologist to be more efficient with both their time and space in their practices. This increase in efficiency can lead directly to increased profits for ophthalmologists. The market for standalone OCT has been around for some time now and so new machines are being sold to replace older technology. Spectral domain equipment is frequently being positioned in the market as a replacement for older time-domain technology.
The unit sale growth of the OCT market is expected to continue; however, it will slow throughout the forecast as the initial growth of hybrid devices also slows. Once this initial growth has ended it should stabilize to a low growth rate correlated to natural growth in the number of ophthalmic practices as populations grow. In addition, the replacement market will be stimulated over the forecast period as early users of OCTs are expected to upgrade to more advanced models. Also, optometrists have begun to purchase standalone OCT equipment.
Both hybrid OCT’s and standalone OCT’s ASPs are expected to slightly increase throughout the forecast. This increase will become more apparent when viewing the total OCT market because hybrid OCT’s are gaining more market share and are a premium device. Technological advancement and the introduction of more hybrid devices will counteract any price drops due to competition.



The "US Market Report Suite for Diagnostic Ophthalmic Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Carl Zeiss Meditec
Topcon
Optovue
Heidelberg Engineering
Haag-Streit
Nidek/Marco
Reichert
Canon
Oculus
Keeler
Sonomed
Quantel

Others

Heine USA
CSO
Zeimer Ophthalmic
Accutome
Tomey
Kowa
iCare
Alcon
DGH Koi
Synemed
AMO
Bausch & Lomb
Merge Healthcare
Others Include: Bioptigen, Bon Optic, CentreVue, Huvitz, iOptics, iViews, JEDMED, Meda, Medmont, Modernizing Medicine, Nianjing RedSun Optical, Nikon, Opto Global, Optomed, Paradigm, Propper Manufacturing, Shin Nippon, Sonogage, Tracey Technologies, Volk, Welch-Allyn, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link